Inari Medical's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Inari Medical (NASDAQ:NARI) is set to release its quarterly earnings on October 28, 2024. Analysts expect an EPS of $-0.11. The company's past performance shows significant price changes post-earnings announcements, with a recent history of missing EPS estimates. Analysts have given Inari a Neutral rating with a potential 30.16% upside. The company's revenue growth is strong, but profitability metrics like net margin and ROE are below industry standards.
October 25, 2024 | 2:03 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Inari Medical is expected to report an EPS of $-0.11. The company's past earnings misses have led to significant stock price declines. Analysts rate the stock as Neutral with a potential 30.16% upside. Investors should watch for guidance updates.
Inari Medical's upcoming earnings report is crucial as past earnings misses have led to significant stock price declines. The Neutral rating and potential upside suggest mixed market sentiment. Investors will be keen on the company's guidance for future growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100